These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2689046)

  • 1. Comparative long-term vasoactive effects of atenolol and carteolol on the properties of the small and large arteries of the upper extremities in human essential hypertension.
    Merli IP; Levenson J; Filitti V; Simon A
    Clin Pharmacol Ther; 1989 Dec; 46(6):686-92. PubMed ID: 2689046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ambulatory blood pressure and heart rate during once-daily, randomized, crossover administration of carteolol and atenolol.
    Saito K; Furuta Y; Sano H; Yokoyama M; Fukuzaki H
    Clin Ther; 1994; 16(2):181-90. PubMed ID: 8062314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the haemodynamics of large arteries induced by single doses of nicardipine, enalapril, atenolol and urapidil.
    Pancera P; Arosio E; Priante F; Ribul M; Zannoni M; Talamini G; Lechi A
    Eur J Clin Pharmacol; 1992; 43(1):7-10. PubMed ID: 1505613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different patterns of peripheral versus central blood pressure in hypertensive patients treated with β-blockers either with or without vasodilator properties or with angiotensin receptor blockers.
    Polónia J; Barbosa L; Silva JA; Bertoquini S
    Blood Press Monit; 2010 Oct; 15(5):235-9. PubMed ID: 20577082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic association between artery shear flow condition and platelet cytosolic free Ca2+ concentration in human hypertension.
    Levenson J; Devynck MA; Pithois-Merli I; Le Quan Sang KH; Filitti V; Simon A
    Clin Sci (Lond); 1990 Dec; 79(6):613-8. PubMed ID: 2176948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective mineralocorticoid receptor blocker eplerenone reduces resistance artery stiffness in hypertensive patients.
    Savoia C; Touyz RM; Amiri F; Schiffrin EL
    Hypertension; 2008 Feb; 51(2):432-9. PubMed ID: 18195160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of long use of a beta-blocker, carteolol, on exercise hemodynamics in hypertensives.
    Katori R; Tashi M; Ohno M; Oogai T; Morishita M; Morii S
    Jpn Circ J; 1985 Jan; 49(1):52-60. PubMed ID: 3968862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive effect of carteolol in thiazide-treated hypertensive subjects.
    Velasquez MT; Byrne D; Hoffmann RG
    J Clin Pharmacol; 1985; 25(8):601-6. PubMed ID: 3908501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical experiences with carteolol in patients with essential hypertension].
    Viehmann P
    Arzneimittelforschung; 1983; 33(2a):322-5. PubMed ID: 6340701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of topical carteolol on the normal human retinal circulation.
    Grunwald JE; Delehanty J
    Invest Ophthalmol Vis Sci; 1992 May; 33(6):1853-6. PubMed ID: 1582788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of central and peripheral haemodynamic effects of dilevalol and atenolol in essential hypertension.
    Tham TC; Silke B; Taylor SH
    J Hum Hypertens; 1990 Jun; 4 Suppl 2():77-83. PubMed ID: 2370647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the renal effects of dilevalol and carteolol in patients with mild to moderate essential hypertension.
    Baba T; Murabayashi S; Tomiyama T; Takebe K
    Eur J Clin Pharmacol; 1990; 38(3):305-7. PubMed ID: 2187701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-blocking effect of single oral doses of carteolol.
    Stoll RW; Cavanaugh JH; MacLeod CM
    Clin Pharmacol Ther; 1981 Nov; 30(5):605-10. PubMed ID: 7297020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemodynamic effects of atenolol, labetalol, pindolol and captopril: a comparison in hypertensive patients with special reference to changes in limb blood flow, heart rate and left ventricular function.
    Roberts DH; Tsao Y; Grimmer SF; Winstanley PA; Orme ML; Breckenridge AM
    Br J Clin Pharmacol; 1987 Aug; 24(2):163-72. PubMed ID: 2887190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remission of mild to moderate hypertension after treatment with carteolol, a beta-adrenoceptor blocker with intrinsic sympathomimetic activity.
    Giles TD; Sander GE; Roffidal L; Thomas MG; Mersch DP; Moyer RR; Burris JF; Mroczek WJ; Brachfeld J
    Arch Intern Med; 1988 Aug; 148(8):1725-8. PubMed ID: 3041936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodynamic long-term effects of a new beta-adrenoceptor blocking drug, atenolol (ICI 66082), in essential hypertension.
    Lund-Johansen P
    Br J Clin Pharmacol; 1976 Jun; 3(3):445-51. PubMed ID: 973971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose response for blood pressure and degree of cardiac beta-blockade with atenolol.
    Marshall AJ; Barritt DW; Heaton S; Harry JD
    Postgrad Med J; 1979 Sep; 55(646):537-40. PubMed ID: 390528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute effects of alpha- and beta-adrenoceptor blockade on plasma atrial natriuretic peptides during exercise in elderly patients with mild hypertension.
    Kohno M; Yokokawa K; Yasunari K; Murakawa K; Kurihara N; Takeda T
    Chest; 1991 Apr; 99(4):847-54. PubMed ID: 1826253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of the haemodynamic interaction between atenolol, a cardioselective beta-adrenoreceptor-blocking agent, and chlorthalidone in hypertensive patients.
    Velasco M; Guevara J; Morillo J; Ramírez A; Urbina-Quintana A; Hernandez-Pieretti O
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():363s-365s. PubMed ID: 396082
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension.
    Flammer AJ; Hermann F; Wiesli P; Schwegler B; Chenevard R; Hürlimann D; Sudano I; Gay S; Neidhart M; Riesen W; Ruschitzka F; Lüscher TF; Noll G; Lehmann R
    J Hypertens; 2007 Apr; 25(4):785-91. PubMed ID: 17351370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.